Olivier Guillaud

3.8k total citations
100 papers, 2.3k citations indexed

About

Olivier Guillaud is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Olivier Guillaud has authored 100 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 43 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Olivier Guillaud's work include Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (36 papers) and Organ Transplantation Techniques and Outcomes (19 papers). Olivier Guillaud is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (36 papers) and Organ Transplantation Techniques and Outcomes (19 papers). Olivier Guillaud collaborates with scholars based in France, Switzerland and China. Olivier Guillaud's co-authors include Jérôme Dumortier, Olivier Boillot, Jean‐Yves Scoazec, Valérie Hervieu, Mélanie Vallin, Thomas Walter, Isabelle Morard, Alain Lachaux, Antoine Hadengue and P Paliard and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Olivier Guillaud

96 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Guillaud France 26 1.3k 1.2k 614 413 274 100 2.3k
Bashar Aqel United States 24 1.3k 1.0× 1.5k 1.2× 755 1.2× 270 0.7× 166 0.6× 92 2.4k
J. Ludwig United States 26 2.0k 1.5× 2.0k 1.7× 1.0k 1.7× 209 0.5× 45 0.2× 55 3.3k
Lidija Orlić Croatia 20 866 0.7× 422 0.3× 370 0.6× 167 0.4× 46 0.2× 70 1.5k
P Paliard France 18 499 0.4× 564 0.5× 584 1.0× 252 0.6× 41 0.1× 83 1.4k
Sukru Emre United States 23 609 0.5× 1.0k 0.8× 1.3k 2.1× 59 0.1× 367 1.3× 45 1.9k
Udeme D. Ekong United States 21 551 0.4× 824 0.7× 1.0k 1.6× 71 0.2× 327 1.2× 53 2.0k
Igal Kam United States 37 1.4k 1.0× 3.5k 2.8× 3.5k 5.7× 116 0.3× 835 3.0× 100 4.9k
H. Franklin Herlong United States 16 580 0.4× 652 0.5× 361 0.6× 134 0.3× 76 0.3× 25 1.4k
Kiran Bambha United States 23 1.4k 1.1× 1.3k 1.0× 729 1.2× 169 0.4× 54 0.2× 50 2.0k
Sushma Saksena United Kingdom 10 2.4k 1.8× 1.5k 1.2× 495 0.8× 365 0.9× 16 0.1× 22 2.6k

Countries citing papers authored by Olivier Guillaud

Since Specialization
Citations

This map shows the geographic impact of Olivier Guillaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Guillaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Guillaud more than expected).

Fields of papers citing papers by Olivier Guillaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Guillaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Guillaud. The network helps show where Olivier Guillaud may publish in the future.

Co-authorship network of co-authors of Olivier Guillaud

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Guillaud. A scholar is included among the top collaborators of Olivier Guillaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Guillaud. Olivier Guillaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumortier, Jérôme, Olivier Guillaud, Olivier Boillot, et al.. (2025). Phosphatidylethanol and urinary ethylglucuronide to assess alcohol consumption after liver transplantation. Liver Transplantation. 32(1). 104–106.
2.
Vanlemmens, Claire, François Parant, Térésa Antonini, et al.. (2025). Performance of Relative Exchangeable Copper for the Diagnosis of Wilson Disease in Acute Liver Failure. Journal of Inherited Metabolic Disease. 48(2). e70024–e70024. 2 indexed citations
3.
Nkontchou, G., Louis d’Altéroche, Sylvie Radenne, et al.. (2024). The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience. Clinics and Research in Hepatology and Gastroenterology. 48(6). 102355–102355.
4.
Steiner, Alexandre A., Olivier Boillot, Mélanie Vallin, et al.. (2024). Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease. Clinical Transplantation. 38(11). e70014–e70014. 1 indexed citations
5.
Guillaud, Olivier, Jean‐Yves Scoazec, Cyrielle Caussy, et al.. (2023). Dual alcohol and metabolic‐related liver disease: Results from a population of liver transplant patients. Liver International. 44(2). 422–432. 2 indexed citations
6.
Mornex, Jean‐François, Julie Traclet, Olivier Guillaud, et al.. (2023). Alpha1-antitrypsin deficiency: An updated review. La Presse Médicale. 52(3). 104170–104170. 5 indexed citations
7.
Guillaud, Olivier, et al.. (2023). Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests. Diagnostics. 13(2). 256–256. 2 indexed citations
8.
Sobesky, Rodolphe, Olivier Guillaud, Philippe Sogni, et al.. (2021). Non-invasive diagnosis and follow-up of rare genetic liver diseases. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101768–101768. 8 indexed citations
9.
Sandahl, Thomas Damgaard, Cécile Pagan, Laurence Lion‐François, et al.. (2021). ATP7B variant spectrum in a French pediatric Wilson disease cohort. European Journal of Medical Genetics. 64(10). 104305–104305. 11 indexed citations
10.
Benech, Nicolas, Maximilien Barret, Jérémie Jacques, et al.. (2020). Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases. United European Gastroenterology Journal. 9(3). 362–369. 9 indexed citations
11.
Guillaud, Olivier, Julie Traclet, Lioara Restier, et al.. (2019). Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency. Clinics and Research in Hepatology and Gastroenterology. 43(1). 77–81. 15 indexed citations
12.
Guillaud, Olivier, Josè Ursic‐Bedoya, Évelyne Decullier, et al.. (2018). Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients. Journal of the American Academy of Dermatology. 79(1). 84–91. 20 indexed citations
13.
Bergère, M. C., et al.. (2018). Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe. Clinics and Research in Hepatology and Gastroenterology. 43(4). 395–402. 15 indexed citations
14.
Walter, Thomas, Olivier Guillaud, Eddy Cotte, et al.. (2016). Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments. United European Gastroenterology Journal. 5(5). 735–741. 16 indexed citations
15.
Laurencin, Chloé, Anne Brunet, Jérôme Dumortier, et al.. (2016). Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients. European Neurology. 77(1-2). 5–15. 18 indexed citations
16.
Pioche, Mathieu, Vincent Lépilliez, Pierre H. Deprez, et al.. (2015). High pressure jet injection of viscous solutions for endoscopic submucosal dissection (ESD): first clinical experience. SHILAP Revista de lepidopterología. 3(4). E368–E372. 9 indexed citations
17.
Dumortier, Jérôme, Olivier Guillaud, & Olivier Boillot. (2013). Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients. Liver Transplantation. 19(5). 529–533. 16 indexed citations
18.
Dumortier, Jérôme, Olivier Guillaud, Gabriella Pittau, et al.. (2010). Introduction of Mycophenolate Mofetil in Maintenance Liver Transplant Recipients: What Can We Expect? Results of a 10-Year Experience. Transplantation Proceedings. 42(7). 2602–2606. 8 indexed citations
19.
Mennesson, Nicolas, Jérôme Dumortier, Valérie Hervieu, et al.. (2009). Liver Steatosis Quantification Using Magnetic Resonance Imaging. Journal of Computer Assisted Tomography. 33(5). 672–677. 42 indexed citations
20.
Gottardi, Andrea De, Laurent Spahr, Isabelle Morard, et al.. (2007). A Simple Score for Predicting Alcohol Relapse After Liver Transplantation. Archives of Internal Medicine. 167(11). 1183–1183. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bashar Aqel Breakdown of academic impact, for papers by J. Ludwig Breakdown of academic impact, for papers by Lidija Orlić Breakdown of academic impact, for papers by P Paliard Breakdown of academic impact, for papers by Sukru Emre Breakdown of academic impact, for papers by Udeme D. Ekong Breakdown of academic impact, for papers by Igal Kam Breakdown of academic impact, for papers by H. Franklin Herlong Breakdown of academic impact, for papers by Kiran Bambha Breakdown of academic impact, for papers by Sushma Saksena
Rankless by CCL
2026